Cancer BiologyCancersPeer-reviewed
Purinergic Ca2+ signaling as a novel mechanism of drug tolerance in BRAF mutant melanoma
Philip E. Stauffer, Jordon Brinkley, David Aaron Jacobson…·Darren R. Tyson
This study identifies purinergic Ca2+ signaling via P2X7 receptors as a mechanism enabling drug tolerance in BRAF-mutant melanoma, with implications for overcoming treatment resistance.
9 citations